Out of a total of 11 patents in existence worldwide covering the production of hydrogen using the clostridia bacteria, NNLX owns 5 of them and has another 22 provisional patents filed covering unique system know-how and features. The newly joined Microbiogist Dr. Sergey Gazenko owns another three patents himself.
Nanologix's technology vs traditional technologies to extract hydrogen:
Most economists and scientists agree that hydrogen will progressively replace oil in the economy of the future: unfortunately, the cost of generating hydrogen fuel from clean, renewable electricity is initially in the range of $4.00-5.00 per equivalent gallon of gasoline, it is still more expensive than gasoline. The number one biggest issue to use hydrogen as an energy is the cost to produce it, in most cases, you need consume energy (electricity) to produce hydrogen.
NOT ANYMORE!
Through the combination of biotechnology and nanotechnology, NNLX is the first company owns a commercially available patented technology to massively produce hydrogen at the least cost without consuming any other kind of energy.
NanoLogix methodology for hydrogen generation is being developed for the limitless production of hydrogen from organic waste and wastewaters. Once fully proven at the Welch facility, this has the potentiality for solving the world energy crisis from any waste organic byproduct, including sewage, and agricultural and food manufacturing waste. The bacterial reaction is self propagating, as the number of bacterias doubles every 24 minutes.
Last year NanoLogix announced the results of a study that confirmed laboratory proof that its bioreactor system generates hydrogen in high yields via the use and adaptation of its intellectual property. In this study, the bioreactor produced biogas consisting of 50% hydrogen by volume, without any trace of methane, which eliminates an additional costly step.
After last year's study results were revealed, the Company signed a feasibility study with the Department of Environmental Science and Engineering of Gannon University in Erie, PA to develop a bioreactor that utilizes NanoLogix's intellectual assets. The project team compromises a distinguished cohort of scientists and university professors who share a common vision.
In July of last year NanoLogix signed an agreement to generate hydrogen from a scale-up bioreactor system installed at Mobilia Fruit Farms in rural Pennsylvania utilizing waste organic matter from the farm Arrowhead Wines unit.
An even bigger scale-up agreement, to install a hydrogen generation system using Welch Food's waste organic matter, followed shortly, the bioreactor is starting to operate as of early April 2008. Welch, of course, is the world's leading producer of grape and other fruit-based food products, giving NanoLogix virtually unlimited scale-up access to the waste-organics.
***** There are already a number of major players are interested the technology, such as BP and Northern Power. *****
***** Bulletin Board application: the financial audit is being completed and it's anticipated that the stock should be traded on OTC BB soon. *****
********************* OS AND FLOAT *********************
As of 04/18/2006:
48 million shares outstanding and approximitely 20 million shares float.
Dr. Sergey Gazenko is an internationally respected Microbiologist, he owns three patents in this field. He will assist in investigating its experimental parameters in order to maximize its efficiency. more on Dr. Gazenko: http://www.mibitec.com/docs/NW-5%20(4).doc
John S. Wisniewski joined Company's Board of Directors. Mr. Wisniewski brings considerable expertise and guidance to NanoLogix in the implementation of international growth initiatives and technology commercialization in addition to lending his longstanding strategic and international business relationships to better the Company's competitive and marketing position of its nanotechnologies, more specifically its medical diagnostic products and hydrogen generation system technologies.
The Company has completed the construction of its first commercial hydrogen bioreactor facility at a Welch's Food plant in North East, Pennsylvania. The company also announced that the facility will begin hydrogen generation from Welch's waste organic matter on or about the first of April 2006.
87 Stambaugh Avenue, Suite 2 Sharon, PA 16146 Voice (724) 346-1302 8:00AM - 5:00PM EST Fax (724) 346-9596
ABOUT NANOLOGIX:
NanoLogix, Inc. is a biotechnology / genomics company owning 31 issued patents with applications in nanotechnology, hydrogen gas production, medical drugs/devices, bio-defense sensors and bioremediation. Nanotechnology applications include Biochips embedded in small transportable devices for rapid bacteria identification of disease causing pathogens, and Bio Micro Electro Mechanical Systems (“BioMEMS”) for rapid environmental microbial monitoring with bio-defense implications. Its hydrogen bioreactor research is designed to assist in worldwide energy independence and reduce pollution using renewable, environmentally-friendly energy sources.
Additionally, NanoLogix owns a patent for the nontoxic induction of apoptosis in cancer cells utilizing hydrophobic hydrocarbons. Apoptosis is a method for inducing a genetically based induction of "cell suicide" in cells. It therefore serves as the foundation for cancer therapy. NanoLogix's other patents include technology designed for use in the bioremediation of contaminated soil and water.
News 
Market Data 
Discover 
AI
